Insulin therapy in type 2 diabetes mellitus

Andrew Ahmann, Matthew C. Riddle

Research output: Chapter in Book/Report/Conference proceedingChapter

9 Citations (Scopus)

Abstract

The prevalence of type 2 diabetes mellitus is increasing at an alarming rate in the United States and around the world (1). It is a very costly disease, both monetarily and in terms of reduced quality of life (2). These costs are the consequence of the multiple debilitating chronic complications of hyperglycemia. The clinician’s therapeutic goal is to avoid and mitigate these complications.

Original languageEnglish (US)
Title of host publicationInsulin Therapy
PublisherCRC Press
Pages113-126
Number of pages14
ISBN (Electronic)9780824744625
ISBN (Print)9780824707118
StatePublished - Jan 1 2002

Fingerprint

Hyperglycemia
Type 2 Diabetes Mellitus
Quality of Life
Insulin
Costs and Cost Analysis
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Ahmann, A., & Riddle, M. C. (2002). Insulin therapy in type 2 diabetes mellitus. In Insulin Therapy (pp. 113-126). CRC Press.

Insulin therapy in type 2 diabetes mellitus. / Ahmann, Andrew; Riddle, Matthew C.

Insulin Therapy. CRC Press, 2002. p. 113-126.

Research output: Chapter in Book/Report/Conference proceedingChapter

Ahmann, A & Riddle, MC 2002, Insulin therapy in type 2 diabetes mellitus. in Insulin Therapy. CRC Press, pp. 113-126.
Ahmann A, Riddle MC. Insulin therapy in type 2 diabetes mellitus. In Insulin Therapy. CRC Press. 2002. p. 113-126
Ahmann, Andrew ; Riddle, Matthew C. / Insulin therapy in type 2 diabetes mellitus. Insulin Therapy. CRC Press, 2002. pp. 113-126
@inbook{23b3eb1b9a66455eb57d4abfe70e1978,
title = "Insulin therapy in type 2 diabetes mellitus",
abstract = "The prevalence of type 2 diabetes mellitus is increasing at an alarming rate in the United States and around the world (1). It is a very costly disease, both monetarily and in terms of reduced quality of life (2). These costs are the consequence of the multiple debilitating chronic complications of hyperglycemia. The clinician’s therapeutic goal is to avoid and mitigate these complications.",
author = "Andrew Ahmann and Riddle, {Matthew C.}",
year = "2002",
month = "1",
day = "1",
language = "English (US)",
isbn = "9780824707118",
pages = "113--126",
booktitle = "Insulin Therapy",
publisher = "CRC Press",

}

TY - CHAP

T1 - Insulin therapy in type 2 diabetes mellitus

AU - Ahmann, Andrew

AU - Riddle, Matthew C.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - The prevalence of type 2 diabetes mellitus is increasing at an alarming rate in the United States and around the world (1). It is a very costly disease, both monetarily and in terms of reduced quality of life (2). These costs are the consequence of the multiple debilitating chronic complications of hyperglycemia. The clinician’s therapeutic goal is to avoid and mitigate these complications.

AB - The prevalence of type 2 diabetes mellitus is increasing at an alarming rate in the United States and around the world (1). It is a very costly disease, both monetarily and in terms of reduced quality of life (2). These costs are the consequence of the multiple debilitating chronic complications of hyperglycemia. The clinician’s therapeutic goal is to avoid and mitigate these complications.

UR - http://www.scopus.com/inward/record.url?scp=0242526342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242526342&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:0242526342

SN - 9780824707118

SP - 113

EP - 126

BT - Insulin Therapy

PB - CRC Press

ER -